Log In
BCIQ
Print this Print this
 

Dopamine receptor

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Dopamine receptor

BCIQ
Print ChartPrint this
Marketed, 7 Marketed, 1 Marketed, 2 Approved, 1 Phase III, 4 Phase II, 8 Phase I/II, 1 Phase I, 1 Phase I, 1 Preclinical, 7
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase IIIApprovedMarketed
Endocrine / Metabolic

-

-

-

-

-

-

2

Gastrointestinal

-

-

-

-

-

-

1

Genitourinary

-

1

-

-

-

-

-

Neurology

7

1

1

8

4

1

7




 Products Targeting Dopamine receptor
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

15

$2,259.4M

$804.1M

$625.9M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today